News
Pfizer has been dealt a stinging blow by the FDA, after it received a second complete response letter from the Angecy regarding its biosimilar for...
Novartis has revealed that its drug Tafinlar (dabrafenib) has received approval from the FDA for use in combination with Mekinist (trametinib) in...
For the first time in English history, new diagnoses of HIV have fallen across the country – the drop was steepest in areas where HIV testing was...
4.3 million people in the EU are affected by rare cancers, and an estimated 500,000 new cases are diagnosed annually; Dr Terese Johansson highlights...
European approval for Novartis' biosimilar version of a Roche blockbuster and a 100-year old Alzheimer's theory is confirmed. Check out the week's...
New research has identified direct evidence that the body’s immune system attacks the brain in Parkinson’s disease, seemingly confirming a theory...
A new study funded by Cancer Research UK and carried out by the University of Cambridge has identified the ages when women are most at risk from...
Hasini Jayatilaka and a team of researchers say they have uncovered the biochemical mechanism which drives cancer cells to break away from a...
Novartis has posted positive news from the Cantos clinical trial study that saw its drug, Canakinumab, pull of a surprise result to reduce the risk...
President Trump spoke often of how pharmaceutical companies were ‘getting away with murder’, in regards to drug pricing, and now the FDA has hinted...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
